242 related articles for article (PubMed ID: 15510323)
41. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
42. Factors related to poor control of blood pressure with antihypertensive drug therapy.
Jokisalo E; Enlund H; Halonen P; Takala J; Kumpusalo E
Blood Press; 2003; 12(1):49-55. PubMed ID: 12699136
[TBL] [Abstract][Full Text] [Related]
43. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
Schühlen H; Abts M; Kastrati D
Herz; 2007 Aug; 32(5):419-25. PubMed ID: 17687532
[TBL] [Abstract][Full Text] [Related]
44. Use of moxonidine in elderly patients with resistant hypertension.
Martin U; Hill C; O' Mahony D
J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
[TBL] [Abstract][Full Text] [Related]
45. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
Pede S; Lombardo M
Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
[TBL] [Abstract][Full Text] [Related]
46. Risk for Obstructive Sleep Apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study.
Gus M; Gonçalves SC; Martinez D; de Abreu Silva EO; Moreira LB; Fuchs SC; Fuchs FD
Am J Hypertens; 2008 Jul; 21(7):832-5. PubMed ID: 18451807
[TBL] [Abstract][Full Text] [Related]
47. The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
Suzuki H; Inoue T; Kobayashi K; Shoda J; Nakamoto H
Adv Perit Dial; 2006; 22():18-23. PubMed ID: 16983932
[TBL] [Abstract][Full Text] [Related]
48. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
49. Blood pressure control in patients initiating antihypertensive therapy.
Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
[TBL] [Abstract][Full Text] [Related]
50. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L
Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey.
Van der Niepen P; Giot C; van de Borne P
J Hypertens; 2008 Oct; 26(10):2057-63. PubMed ID: 18806631
[TBL] [Abstract][Full Text] [Related]
52. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
53. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
[TBL] [Abstract][Full Text] [Related]
54. [Arterial hypertension in children with end-stage renal failure treated with hemodialysis].
Szczepańska M; Szprynger K; Adamczyk P; Trembecka-Dubel E; Oświecimska J
Pol Merkur Lekarski; 2005 Jan; 18(103):17-21. PubMed ID: 15859540
[TBL] [Abstract][Full Text] [Related]
55. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
56. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
Chazot C
J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
[TBL] [Abstract][Full Text] [Related]
57. Predictors for quality of life in continuous ambulatory peritoneal dialysis patients.
Bilgic A; Akman B; Sezer S; Ozisik L; Arat Z; Ozdemir FN; Haberal M
Nephrology (Carlton); 2008 Oct; 13(7):587-92. PubMed ID: 18522701
[TBL] [Abstract][Full Text] [Related]
58. [Gastroesophageal reflux disease and its' influence on nutritional status in patients treated with peritoneal dialysis].
Stojakowska M; Błaut U; Smoleńiski O; Thor PJ
Folia Med Cracov; 2005; 46(3-4):59-66. PubMed ID: 17252988
[TBL] [Abstract][Full Text] [Related]
59. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT).
Zazgornik J; Biesenbach G; Forstenlehner M; Stummvoll K
Clin Nephrol; 1997 Dec; 48(6):337-40. PubMed ID: 9438090
[TBL] [Abstract][Full Text] [Related]
60. The effectiveness of intensive nursing care on seasonal variation of blood pressure in patients on peritoneal dialysis.
Quan L; Dong J; Li Y; Zuo L
J Adv Nurs; 2012 Jun; 68(6):1267-75. PubMed ID: 22032423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
